Pfizer Says Viagra May Work as Fast as Rivals
Monday, 02 December 2002
LONDON (Reuters Health) - Half of men taking Viagra can have sex within 20 minutes, Pfizer said on Monday as it fought off claims that its blockbuster impotence drug is slower-acting than rivals set to hit the market next year.
read more
|
Erectile Dysfunction Responds to Treatment with Korean Red Ginseng
Friday, 22 November 2002
NEW YORK (Reuters Health) - More than half of men with erectile dysfunction in a preliminary study reported improved erections while taking Korean red ginseng, investigators in Korea report in the Journal of Urology for November.
read more
|
Lilly Says not yet Ready to Make Tadalafil in Europe
Friday, 15 November 2002
LONDON (Reuters Health) - Eli Lilly said on Friday that its erectile dysfunction drug tadalafil (Cialis) could not be launched immediately in Europe following a switch in manufacturing sites.
read more
|
Antiretroviral Agents Associated with Sexual Dysfunction in HIV-infected Men
Tuesday, 12 November 2002
NEW YORK (Reuters Health) - Antiretroviral drugs, especially protease inhibitors (PIs), seem to be related to sexual dysfunction in men with HIV infection, according to a prospective analysis conducted in Spain. Neither hypophyseal hypogonadism nor testicular failure appears to play a part, according to the report in the November 1st issue of the Journal of Acquired Immune Deficiency Syndromes.
read more
|
Viagra Offers Blueprint for Rationing
Tuesday, 12 November 2002
NEW YORK (Reuters Health) - What four industrialized nations did to offset the financial threat posed by covering the erectile dysfunction (ED) treatment Viagra may serve as a blueprint for future coverage of so-called lifestyle drugs, a European research team reported on Tuesday.
read more
|
Tap Pharmaceutical Products Inc. Submits New Drug Application for UPRIMA® (Apomorphine HCL Tablets) Sublingual for Treatment of Erectile Dysfunction
Tuesday, 29 October 2002
LAKE FOREST, Ill., Oct. 29, 2002 - TAP Pharmaceutical Products Inc. announced today that it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration for UPRIMA® (apomorphine HCl tablets) sublingual for the treatment of erectile dysfunction (ED). The NDA includes data for 2 mg and 3 mg doses.
read more
|
MacroChem Trials Halted by FDA on Carcinogenicity Fears
Monday, 14 October 2002
NEW YORK (Reuters Health) - MacroChem Corp. said on Friday that US regulators have halted trials of the firm's topical drugs containing SEPA because of concerns about the absorption-enhancer's potential to cause cancer.
read more
|
Vardenafil Shows Encouraging Results for Treatment of Erectile Dysfunction
Monday, 23 September 2002
LONDON (Reuters Health) - Most men treated with vardenafil (Levitra) for erectile dysfunction experienced markedly improved erections, according to results of phase III trials presented Monday at the World Congress of the International Society for Sexual and Impotence Research in Montreal.
read more
|
Beta-blocker-related Erectile Dysfunction Often Psychogenic
Thursday, 05 September 2002
BERLIN (Reuters Health) - Erectile dysfunction (ED) associated with beta-blocker use may in part be psychological and related to a general knowledge that the drugs are associated with such difficulties, according to research presented here at the European Society of Cardiology congress.
read more
|
Sildenafil may Improve Endothelial Function in Type 2 Diabetics
Friday, 30 August 2002
NEW YORK (Reuters Health) - In patients with type 2 diabetes, treatment with the anti-impotence drug sildenafil (Viagra) appears to improve flow-mediated dilatation (FMD), an index of nitric oxide-dependent endothelial function, according to a recent report.
read more
|
Diabetes Duration Influences Risk of Erectile Dysfunction
Thursday, 22 August 2002
NEW YORK (Reuters Health) - A longer duration of type 2 diabetes significantly enhances the already high risk of erectile dysfunction in men over 50, according to a report in the August issue of Diabetes Care.
read more
|
Sildenafil Effective for Erectile Dysfunction in CHF Patients
Tuesday, 06 August 2002
NEW YORK (Reuters Health) - Erectile dysfunction, which is common among patients with congestive heart failure (CHF), is treatable with sildenafil (Viagra) and also improves exercise capacity in these patients, according to the results of a randomized trial.
read more
|
New Intracavernous Therapy Safe and Well Tolerated by Men with ED
Wednesday, 19 June 2002
NEW YORK (Reuters Health) - PNU-83757, a novel erectogenic potassium channel opener, is safe and well tolerated in men with erectile dysfunction (ED), researchers report in the June issue of The Journal of Urology.
read more
|
Pfizer Loses UK Battle on Viagra Patent
Monday, 17 June 2002
LONDON (Reuters) - Pfizer Inc. has lost its final attempt to overthrow a British court ruling invalidating a UK patent on a key ingredient of its blockbuster impotence drug Viagra.
read more
|
Impotence Drug Tadalafil Demonstrates Long-lasting Effect
Friday, 31 May 2002
ORLANDO, Florida (Reuters Health) - Men with erectile dysfunction can have sexual intercourse for up to 36 hours after taking a single dose of the investigational phosphodiesterase inhibitor tadalafil (Cialis), according to study findings presented here at the American Urological Association's annual meeting.
read more
|
Erectile Dysfunction (ED) 
